Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal

• by Sabela Lens, Alice R Burton, Jessica Davies, Maelle Locatelli, Mireia García-López, Anna Pocurull, Anna Jeffery-Smith, Nikolai Novikov, Simon P Fletcher, Xavier Forns, Sofía Pérez-del-Pulgar, Mala K Maini

• August 1, 2026

Development and internal validation of a frailty risk stratification model for older patients with spinal tuberculosis

• by Yu Luo, Yi Wang, Bangyan Guan, Jiarong Tan, Jiahui Zhang, Jiao Luo, Ling Tang, Xin Huang

• July 21, 2026

Estimation of populations at risk for severe influenza and vaccination coverage in Mexico, 2010–2021

• by Arturo Galindo-Fraga, Gerardo Luna-Casas, Ricardo Gasca-Pineda, Gilberto Sánchez-González

• July 21, 2026

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.

• by Teraya Smith

• July 23, 2026

• 3 min